SCHEMBL5886783

SCHEMBL5886783

Cc1nc(N2CCN(c3ccccn3)CC2)nc2c1ccc(=O)n2-c1ccc(C(N)=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.44
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.40
HK1 P19367 1/20 0.40
RAB9A P51151 1/20 0.40
HKDC1 Q2TB90 1/20 0.40
HPGD P15428 3/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC6A7 Q99884 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886849 0.92 KDM4E (0.43) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5886843 0.91 KDM4E (0.43) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5886830 0.88 ALDH1A1 (0.42) CHEK2ALDH1A1MEN1KMT2AMAPT
SCHEMBL5887121 0.87 GPR119 (0.41) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5887071 0.86 DRD2 (0.48) KDM4EALDH1A1LMNASMN1; SMN2CTNNB1
SCHEMBL5887094 0.85 PDE10A (0.44) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL5887184 0.85 CHEK1 (0.46) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL5887267 0.85 CTNNB1 (0.45) KDM4EALDH1A1MAPTRAB9APOLB
SCHEMBL5886806 0.85 ALDH1A1 (0.36) KDM4EALDH1A1MAPTL3MBTL1HPGD
SCHEMBL5886744 0.84 MGLL (0.46) ALDH1A1MAPTPOLBLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP CHEK2 71/4885KDM4E 840/4885ALDH1A1 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.